Soft Tissue Regeneration, Inc.
1266 East Main Street, Suite 700R
Stamford, CT

Soft Tissue Regeneration Inc. is advancing a breakthrough technology to treat anterior cruciate ligament (ACL) injuries – common among active athletes. The company’s patented technology is expected to improve healing for patients. Its L-C Ligament™ product is a biocompatible and degradable synthetic braided scaffold that replaces a torn ACL and encourages the regeneration of ligament tissue.

The president of STR cites two reasons for moving the company to Connecticut from Virginia: the relocation of STR’s scientific founder, Dr. Cato Laurencin…and Connecticut Innovations. Laurencin, an internationally renowned orthopedic surgeon, moved to Connecticut from Virginia in mid-2008 to become dean of the University of Connecticut Medical School and vice president of health services for the university. While this development was significant, STR’s relationship with CI was the deciding factor in the company’s decision to relocate.

“I was impressed by CI’s professionalism and depth of experience in working with startups. I was also interested in opportunities to be introduced to members of Connecticut’s technology and business communities.” – Joe Reilly, president, CEO and founder of STR

Impressed by STR’s technology and talented team of scientists and executives, CI signed off on an investment of $750,000 in STR in June 2009, part of a $3.5 million Series A round.

“Our experience in working with CI’s investment team has been extremely positive. CI’s team has demonstrated that they understand our issues and concerns. And the entire process, from due diligence through closing, went very efficiently and smoothly, proving again that they are an experienced bunch.” – Joe Reilly

STR settled into its Stamford office in August 2009. The company is in discussions with prospective investors and has initiated Phase I animal trials.

www.softtissueregeneration.com